Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

• Conventional treatments fail in about 20% of antiphospholipid syndrome pregnancies. • Therapy for high-risk antiphospholipid syndrome pregnancies is not yet established. • Apheresis plus intravenous immunoglobulins were evaluated as a second-line therapy. • The combined therapy outlined here led t...
Ausführliche Beschreibung

• Conventional treatments fail in about 20% of antiphospholipid syndrome pregnancies. • Therapy for high-risk antiphospholipid syndrome pregnancies is not yet established. • Apheresis plus intravenous immunoglobulins were evaluated as a second-line therapy. • The combined therapy outlined here led to a high birth rate and no side-effects. Ausführliche Beschreibung